Juvenile systemic sclerosis: A follow-up study of eight patients

Szilvia Szamosi, L. Máródi, L. Czirják, Zoltán Ellenes, G. Szűcs

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Juvenile systemic sclerosis (JSSc) is a rare form of systemic sclerosis (also known as scleroderma). Fewer than 10% of SSc cases have their onset before age 20 and fewer than 2% before the age of 10. Few case reports and cohort studies on jSSc have been published. Our objective was to assess the clinical and laboratory characteristics of eight cases of juvenile-onset SSc followed up at our institution. Clinical manifestations of SSc were recorded, and immunologic laboratory tests including antinuclear antibodies (ANAs), anti-centromere antibodies (ACAs), and anti-Scl-70 antibodies were assessed. The female-to-male ratio was 7:1, and age at onset ranged from 3-17 years. At the time of analysis, 2 of 8 patients were still under 18 years of age, and 6 of 8 patients were adults. The mean follow-up period from the onset of disease was 19.1 years. Raynaud's phenomenon was present in all cases. Only 2 of 8 patients had diffuse SSc. During follow-up, pulmonary fibrosis developed in only 2 of 8 patients and cardiovascular manifestations in 3 of 8 patients. Secondary sicca syndrome was present in 2 of 8 cases. Regarding immunologic laboratory markers, 7 of 8 patients were ANA positive. However, none of these patients ever carried anti-Scl-70 antibodies, and only 2 of 8 patients had ever had ACA seropositivity. Our results suggest that in jSSc, Raynaud's phenomenon is more severe, whereas internal organ manifestations and the frequency of autoantibodies are far less pronounced than in adult-onset SSc. Also, the survival rate and final outcome of patients with jSSc appear to be better than those in patients with adult-onset SSc.

Original languageEnglish
Pages (from-to)229-234
Number of pages6
JournalAnnals of the New York Academy of Sciences
Volume1051
DOIs
Publication statusPublished - 2005

Fingerprint

Systemic Scleroderma
Antinuclear Antibodies
Antibodies
Autoantibodies
Anti-Idiotypic Antibodies
Raynaud Disease
Centromere
Age of Onset
Biomarkers
Immunologic Tests
Pulmonary Fibrosis
Sjogren's Syndrome
Onset
Cohort Studies
Survival Rate

Keywords

  • Connective tissue disease
  • Fibrosis
  • Juvenile systemic sclerosis
  • Raynaud's phenomenon
  • Scleroderma

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Juvenile systemic sclerosis : A follow-up study of eight patients. / Szamosi, Szilvia; Máródi, L.; Czirják, L.; Ellenes, Zoltán; Szűcs, G.

In: Annals of the New York Academy of Sciences, Vol. 1051, 2005, p. 229-234.

Research output: Contribution to journalArticle

@article{e5147ad6a6a54162b90fae82d08e1ae6,
title = "Juvenile systemic sclerosis: A follow-up study of eight patients",
abstract = "Juvenile systemic sclerosis (JSSc) is a rare form of systemic sclerosis (also known as scleroderma). Fewer than 10{\%} of SSc cases have their onset before age 20 and fewer than 2{\%} before the age of 10. Few case reports and cohort studies on jSSc have been published. Our objective was to assess the clinical and laboratory characteristics of eight cases of juvenile-onset SSc followed up at our institution. Clinical manifestations of SSc were recorded, and immunologic laboratory tests including antinuclear antibodies (ANAs), anti-centromere antibodies (ACAs), and anti-Scl-70 antibodies were assessed. The female-to-male ratio was 7:1, and age at onset ranged from 3-17 years. At the time of analysis, 2 of 8 patients were still under 18 years of age, and 6 of 8 patients were adults. The mean follow-up period from the onset of disease was 19.1 years. Raynaud's phenomenon was present in all cases. Only 2 of 8 patients had diffuse SSc. During follow-up, pulmonary fibrosis developed in only 2 of 8 patients and cardiovascular manifestations in 3 of 8 patients. Secondary sicca syndrome was present in 2 of 8 cases. Regarding immunologic laboratory markers, 7 of 8 patients were ANA positive. However, none of these patients ever carried anti-Scl-70 antibodies, and only 2 of 8 patients had ever had ACA seropositivity. Our results suggest that in jSSc, Raynaud's phenomenon is more severe, whereas internal organ manifestations and the frequency of autoantibodies are far less pronounced than in adult-onset SSc. Also, the survival rate and final outcome of patients with jSSc appear to be better than those in patients with adult-onset SSc.",
keywords = "Connective tissue disease, Fibrosis, Juvenile systemic sclerosis, Raynaud's phenomenon, Scleroderma",
author = "Szilvia Szamosi and L. M{\'a}r{\'o}di and L. Czirj{\'a}k and Zolt{\'a}n Ellenes and G. Szűcs",
year = "2005",
doi = "10.1196/annals.1361.063",
language = "English",
volume = "1051",
pages = "229--234",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Juvenile systemic sclerosis

T2 - A follow-up study of eight patients

AU - Szamosi, Szilvia

AU - Máródi, L.

AU - Czirják, L.

AU - Ellenes, Zoltán

AU - Szűcs, G.

PY - 2005

Y1 - 2005

N2 - Juvenile systemic sclerosis (JSSc) is a rare form of systemic sclerosis (also known as scleroderma). Fewer than 10% of SSc cases have their onset before age 20 and fewer than 2% before the age of 10. Few case reports and cohort studies on jSSc have been published. Our objective was to assess the clinical and laboratory characteristics of eight cases of juvenile-onset SSc followed up at our institution. Clinical manifestations of SSc were recorded, and immunologic laboratory tests including antinuclear antibodies (ANAs), anti-centromere antibodies (ACAs), and anti-Scl-70 antibodies were assessed. The female-to-male ratio was 7:1, and age at onset ranged from 3-17 years. At the time of analysis, 2 of 8 patients were still under 18 years of age, and 6 of 8 patients were adults. The mean follow-up period from the onset of disease was 19.1 years. Raynaud's phenomenon was present in all cases. Only 2 of 8 patients had diffuse SSc. During follow-up, pulmonary fibrosis developed in only 2 of 8 patients and cardiovascular manifestations in 3 of 8 patients. Secondary sicca syndrome was present in 2 of 8 cases. Regarding immunologic laboratory markers, 7 of 8 patients were ANA positive. However, none of these patients ever carried anti-Scl-70 antibodies, and only 2 of 8 patients had ever had ACA seropositivity. Our results suggest that in jSSc, Raynaud's phenomenon is more severe, whereas internal organ manifestations and the frequency of autoantibodies are far less pronounced than in adult-onset SSc. Also, the survival rate and final outcome of patients with jSSc appear to be better than those in patients with adult-onset SSc.

AB - Juvenile systemic sclerosis (JSSc) is a rare form of systemic sclerosis (also known as scleroderma). Fewer than 10% of SSc cases have their onset before age 20 and fewer than 2% before the age of 10. Few case reports and cohort studies on jSSc have been published. Our objective was to assess the clinical and laboratory characteristics of eight cases of juvenile-onset SSc followed up at our institution. Clinical manifestations of SSc were recorded, and immunologic laboratory tests including antinuclear antibodies (ANAs), anti-centromere antibodies (ACAs), and anti-Scl-70 antibodies were assessed. The female-to-male ratio was 7:1, and age at onset ranged from 3-17 years. At the time of analysis, 2 of 8 patients were still under 18 years of age, and 6 of 8 patients were adults. The mean follow-up period from the onset of disease was 19.1 years. Raynaud's phenomenon was present in all cases. Only 2 of 8 patients had diffuse SSc. During follow-up, pulmonary fibrosis developed in only 2 of 8 patients and cardiovascular manifestations in 3 of 8 patients. Secondary sicca syndrome was present in 2 of 8 cases. Regarding immunologic laboratory markers, 7 of 8 patients were ANA positive. However, none of these patients ever carried anti-Scl-70 antibodies, and only 2 of 8 patients had ever had ACA seropositivity. Our results suggest that in jSSc, Raynaud's phenomenon is more severe, whereas internal organ manifestations and the frequency of autoantibodies are far less pronounced than in adult-onset SSc. Also, the survival rate and final outcome of patients with jSSc appear to be better than those in patients with adult-onset SSc.

KW - Connective tissue disease

KW - Fibrosis

KW - Juvenile systemic sclerosis

KW - Raynaud's phenomenon

KW - Scleroderma

UR - http://www.scopus.com/inward/record.url?scp=25444441751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444441751&partnerID=8YFLogxK

U2 - 10.1196/annals.1361.063

DO - 10.1196/annals.1361.063

M3 - Article

C2 - 16126963

AN - SCOPUS:25444441751

VL - 1051

SP - 229

EP - 234

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -